Responses
Clinical/translational cancer immunotherapy
Original research
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.
